Regulatory Rampage: Bombay HC Declares Unlicensed Cosmetics ‘Illegal Invaders’ No Mercy for Glamstone’s ₹10 Crore Gamble

Background of the Case

In November 2025, Glamstone Cosmetics Pvt. Ltd. imported three consignments of cosmetics and FMCG items from the UAE, with a total declared value exceeding ₹10 crore. Instead of seeking immediate clearance for home consumption, the company filed warehousing Bills of Entry, planning to store the products in bonded warehouses in India (due to lower storage costs) and later re-exportthem to other countries.

The company had applied for the mandatory CDSCO registration (under the Drugs and Cosmetics Act, 1940, and Cosmetics Rules, 2020) back in May 2025 but hadn’t received it yet. They argued that since the goods weren’t entering the Indian market for sale, no CDSCO license was required at the import stage.

However, the Directorate of Revenue Intelligence (DRI) seized the consignments on November 26, 2025, under Section 110 of the Customs Act, 1962, suspecting them to be prohibited goods due to the missing CDSCO registration. Glamstone challenged the seizure in the Bombay High Court, seeking to quash the action and allow re-export at their own cost.

The Court’s Key Findings

A Division Bench comprising Justice G.S. Kulkarni and Justice Aarti Sathe dismissed the petition entirely. Here’s why, in straightforward terms:

• “Import” happens the moment goods enter Indian territory — The court clarified that bringing goods into India (even for warehousing) qualifies as an import under the Customs Act. The definition doesn’t distinguish based on ultimate intent (sale vs. re-export).
• CDSCO registration is mandatory for all cosmetic imports — Section 10 of the Drugs and Cosmetics Act, read with the Cosmetics Rules, 2020, requires a registration certificate from the Central Drugs Standard Control Organisation (CDSCO) for importing cosmetics. No exceptions for bonded warehousing or re-export plans.
• Non-compliance makes goods “prohibited” — Without the license, the consignments fell under the category of prohibited goods (Section 2(33) of the Customs Act), making them liable for seizure (Section 110) and potential confiscation (Section 111).
• Future intent doesn’t cure the initial illegality — The court rejected the argument that a later re-export would fix the problem. “Intention to warehouse and subsequently re-export shall not cure the illegality of the initial import,” as one legal analysis put it. Allowing such loopholes could undermine public health safeguards against sub-standard or unregulated products.

The bench upheld the seizure and refused permission for re-export. The matter remains open for further customs investigation and adjudication.

(Note: An initial article on Medical Dialogues from March 15, 2026, carried a headline suggesting the court “permitted” re-export, but this appears inconsistent with the full judgment and reports from LiveLaw, Verdictum, Indian Kanoon, and others, which confirm the petition was dismissed and re-export denied.)

Why This Ruling Matters for the Industry

This decision tightens enforcement around cosmetic imports and has broader implications:

• Importers can no longer use bonded warehousing as a workaround to delay or avoid regulatory approvals.
• It reinforces that India’s drug and cosmetic regulations prioritize consumer safety over commercial convenience.
• Businesses dealing in imports (cosmetics, drugs, or similar regulated goods) must secure all clearances before goods land in India “import first, comply later” strategy.
• Expect stricter scrutiny from customs/DRI on warehousing declarations, especially for high-value consignments from regions like the UAE/Dubai.

For companies like Glamstone, this could mean significant financial losses (seized goods worth crores), potential penalties, and a lesson in proactive compliance.

Takeaway for Importers and Businesses

If you’re in the import-export space for cosmetics, beauty products, or FMCG items under regulatory oversight:

1. Always obtain CDSCO registration prior to importation.
2. Don’t rely on warehousing/re-export as a fallback compliance is non-negotiable at entry.
3. Consult legal/customs experts early to avoid seizures that tie up capital and invite investigations.

This judgment strengthens India’s regulatory framework and serves as a reminder: Public health regulations trump logistical shortcuts. Importers ignoring this do so at their own risk.

What are your thoughts on this ruling? Have you faced similar customs hurdles in imports? Share in the comments!

(Sources: Bombay High Court judgment via Indian Kanoon, LiveLaw, Verdictum.in, and related legal reports – March 2026)